Biktarvy, formally known as bictegravir, includes a powerful single-tablet therapy for treating HIV infection. This formula unites three crucial antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the the viral ability to multiply within the body, considerably reducing the viral load. For many individua